Companies: 10,795·Total market cap: $144.5T
Sesen Bio, Inc.

Sesen Bio, Inc.

SESNNASDAQHealthcare
$0.63
+$0.04(+7.29%)
Market Cap$127955770
P/E Ratio
52W High$0.965
52W Low$0.365

Sesen Bio, Inc. (SESN) Revenue

Annual & quarterly revenue history · segment & region breakdown

SESN · revenue · updated Jun 9, 2026

Core revenue metrics

Sesen Bio, Inc. trailing twelve-month (TTM) revenue is $-0.01B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$-0.01B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$-625K
17 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Sesen Bio, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
SESN revenue by year · SESN revenue history · SESN annual revenue data

Compare revenue vs peers

Biotechnology

Compare SESN revenue against listed peers. Click any row to open that company's revenue tab.

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Sesen Bio, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Sesen Bio, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Sesen Bio, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

SESN revenue · 4 questions

SESN's trailing twelve-month (TTM) revenue is $-0.01B. That is an increase of 0.00% year-over-year from — in FY.

SESN revenueSESN annual revenuewhat is SESN revenueSESN TTM revenue

Source: FMP · Sesen Bio, Inc. SEC filings · GAAP · Sesen Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026